Scaling the Advanced Therapy Supply Chain

SOTIO is currently testing the safety and efficiency of DCVAC/PCa treatment in an extensive global multi-center Phase III clinical trial for prostate cancer immunotherapy called the VIABLE study.

SOTIO had delivered early trials by using its in-house cryo-store and shipping under dry-ice to recipient centres. The plan was to scale this system into the PhIII trial. However, this proved to be impractical and too expensive.

This case study describes the use of dispersed storage and cold chain logistics, around a central manufacturing facility, to create a cost efficient and robust supply chain.

Download our collaborative case study with SOTIO to learn more about the supply chain barriers associated with this clinical trial and how Fisher BioServices' CryoHubSM infrastructure offered a solution.

Sotio case study Cover.jpg

Download Case Study Here